ID   MEX5_CAEEL              Reviewed;         468 AA.
AC   Q9XUB2;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   18-JUN-2025, entry version 147.
DE   RecName: Full=Zinc finger protein mex-5;
GN   Name=mex-5 {ECO:0000312|WormBase:W02A2.7};
GN   ORFNames=W02A2.7 {ECO:0000312|WormBase:W02A2.7};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION.
RX   PubMed=10882103; DOI=10.1016/s1097-2765(00)80246-4;
RA   Schubert C.M., Lin R., de Vries C.J., Plasterk R.H., Priess J.R.;
RT   "MEX-5 and MEX-6 function to establish soma/germline asymmetry in early C.
RT   elegans embryos.";
RL   Mol. Cell 5:671-682(2000).
RN   [3]
RP   FUNCTION, INTERACTION WITH PLK-1 AND PLK-2, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, PHOSPHORYLATION AT THR-186, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF THR-186.
RX   PubMed=18199581; DOI=10.1242/dev.013425;
RA   Nishi Y., Rogers E., Robertson S.M., Lin R.;
RT   "Polo kinases regulate C. elegans embryonic polarity via binding to DYRK2-
RT   primed MEX-5 and MEX-6.";
RL   Development 135:687-697(2008).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, PHOSPHORYLATION AT
RP   SER-458, AND MUTAGENESIS OF SER-458.
RX   PubMed=18842813; DOI=10.1242/dev.027060;
RA   Tenlen J.R., Molk J.N., London N., Page B.D., Priess J.R.;
RT   "MEX-5 asymmetry in one-cell C. elegans embryos requires PAR-4- and PAR-1-
RT   dependent phosphorylation.";
RL   Development 135:3665-3675(2008).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26096734; DOI=10.1016/j.devcel.2015.05.024;
RA   Elewa A., Shirayama M., Kaymak E., Harrison P.F., Powell D.R., Du Z.,
RA   Chute C.D., Woolf H., Yi D., Ishidate T., Srinivasan J., Bao Z.,
RA   Beilharz T.H., Ryder S.P., Mello C.C.;
RT   "POS-1 Promotes Endo-mesoderm Development by Inhibiting the Cytoplasmic
RT   Polyadenylation of neg-1 mRNA.";
RL   Dev. Cell 34:108-118(2015).
RN   [6]
RP   FUNCTION.
RX   PubMed=27594427; DOI=10.1016/j.cell.2016.08.006;
RA   Saha S., Weber C.A., Nousch M., Adame-Arana O., Hoege C., Hein M.Y.,
RA   Osborne-Nishimura E., Mahamid J., Jahnel M., Jawerth L., Pozniakovski A.,
RA   Eckmann C.R., Juelicher F., Hyman A.A.;
RT   "Polar positioning of phase-separated liquid compartments in cells
RT   regulated by an mRNA competition mechanism.";
RL   Cell 166:1572-1584(2016).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=30279189; DOI=10.1534/g3.118.200744;
RA   Gauvin T.J., Han B., Sun M.J., Griffin E.E.;
RT   "PIE-1 Translation in the Germline Lineage Contributes to PIE-1 Asymmetry
RT   in the Early Caenorhabditis elegans Embryo.";
RL   G3 (Bethesda) 8:3791-3801(2018).
CC   -!- FUNCTION: Functions with mex-6 to affect embryonic viability, establish
CC       soma germline asymmetry in embryos and establish plk-1, pie-1, mex-1,
CC       and pos-1 asymmetry in embryos (PubMed:10882103, PubMed:18199581,
CC       PubMed:18842813, PubMed:30279189). Also affects formation of intestinal
CC       cells (PubMed:10882103). Binds to mRNA in vitro, and inhibits pgl-3-
CC       mediated P-granule formation, probably by competing with pgl-3 for
CC       binding to mRNA (PubMed:27594427). Required for neg-1 expression in
CC       anterior blastomeres during embryogenesis (PubMed:26096734).
CC       {ECO:0000269|PubMed:10882103, ECO:0000269|PubMed:18199581,
CC       ECO:0000269|PubMed:18842813, ECO:0000269|PubMed:26096734,
CC       ECO:0000269|PubMed:27594427, ECO:0000269|PubMed:30279189}.
CC   -!- SUBUNIT: Interacts (when phosphorylated on Thr-186) with plk-1 (via
CC       POLO box domain) and plk-2 (via POLO box domain).
CC       {ECO:0000269|PubMed:18199581}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18199581,
CC       ECO:0000269|PubMed:18842813}.
CC   -!- TISSUE SPECIFICITY: Asymmetrically localized to the anterior of the
CC       zygote before mitotic division, then differentially distributed to the
CC       somatic blastomere precursor cells. {ECO:0000269|PubMed:18199581,
CC       ECO:0000269|PubMed:18842813}.
CC   -!- PTM: Phosphorylation on Ser-458 by par-1 promotes localization of the
CC       protein to the anterior cytoplasm of the zygote (PubMed:18842813).
CC       Phosphorylation by mbk-1 appears to be required for subsequent
CC       phosphorylation by plk-1 (PubMed:18199581).
CC       {ECO:0000269|PubMed:18199581, ECO:0000269|PubMed:18842813}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown reduces the expression of
CC       pie-1 in P2 blastomeres (PubMed:30279189). Abolishes neg-1 expression
CC       in anterior blastomeres (PubMed:26096734). RNAi-mediated knockdown in
CC       mex-6 pk440 mutant background causes a loss in plk-1 asymmetric
CC       distribution during the first embryonic cell divisions.
CC       {ECO:0000269|PubMed:18199581, ECO:0000269|PubMed:26096734,
CC       ECO:0000269|PubMed:30279189}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284604; CAB05310.1; -; Genomic_DNA.
DR   PIR; T26081; T26081.
DR   RefSeq; NP_502566.1; NM_070165.7.
DR   PDB; 6PMG; NMR; -; X=312-346.
DR   PDBsum; 6PMG; -.
DR   AlphaFoldDB; Q9XUB2; -.
DR   BMRB; Q9XUB2; -.
DR   SMR; Q9XUB2; -.
DR   BioGRID; 43384; 24.
DR   FunCoup; Q9XUB2; 376.
DR   IntAct; Q9XUB2; 3.
DR   STRING; 6239.W02A2.7.1; -.
DR   BindingDB; Q9XUB2; -.
DR   ChEMBL; CHEMBL1293319; -.
DR   DrugCentral; Q9XUB2; -.
DR   iPTMnet; Q9XUB2; -.
DR   PaxDb; 6239-W02A2.7; -.
DR   PeptideAtlas; Q9XUB2; -.
DR   EnsemblMetazoa; W02A2.7.1; W02A2.7.1; WBGene00003230.
DR   GeneID; 178296; -.
DR   KEGG; cel:CELE_W02A2.7; -.
DR   UCSC; W02A2.7; c. elegans.
DR   AGR; WB:WBGene00003230; -.
DR   CTD; 178296; -.
DR   WormBase; W02A2.7; CE21237; WBGene00003230; mex-5.
DR   eggNOG; KOG1677; Eukaryota.
DR   GeneTree; ENSGT00970000196404; -.
DR   HOGENOM; CLU_584274_0_0_1; -.
DR   InParanoid; Q9XUB2; -.
DR   OMA; YHRVMEH; -.
DR   OrthoDB; 410307at2759; -.
DR   Reactome; R-CEL-450385; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA.
DR   Reactome; R-CEL-450513; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA.
DR   CD-CODE; 0F0CDB11; Synthetic Condensate 000073.
DR   CD-CODE; 73A75392; P-granule.
DR   CD-CODE; 97E999E0; Synthetic Condensate 000219.
DR   PRO; PR:Q9XUB2; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00003230; Expressed in germ line (C elegans) and 4 other cell types or tissues.
DR   GO; GO:0005813; C:centrosome; IDA:WormBase.
DR   GO; GO:0005737; C:cytoplasm; IDA:WormBase.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0043186; C:P granule; IDA:WormBase.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:WormBase.
DR   GO; GO:0008187; F:poly-pyrimidine tract binding; IDA:WormBase.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:WormBase.
DR   GO; GO:0019901; F:protein kinase binding; IPI:WormBase.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:WormBase.
DR   FunFam; 4.10.1000.10:FF:000018; Zinc finger protein; 1.
DR   Gene3D; 4.10.1000.10; Zinc finger, CCCH-type; 2.
DR   InterPro; IPR045877; ZFP36-like.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR036855; Znf_CCCH_sf.
DR   PANTHER; PTHR12547; CCCH ZINC FINGER/TIS11-RELATED; 1.
DR   PANTHER; PTHR12547:SF18; PROTEIN TIS11; 1.
DR   Pfam; PF00642; zf-CCCH; 1.
DR   SMART; SM00356; ZnF_C3H1; 2.
DR   SUPFAM; SSF90229; CCCH zinc finger; 2.
DR   PROSITE; PS50103; ZF_C3H1; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Developmental protein; DNA-binding; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; RNA-binding; Zinc; Zinc-finger.
FT   CHAIN           1..468
FT                   /note="Zinc finger protein mex-5"
FT                   /id="PRO_0000089183"
FT   ZN_FING         270..299
FT                   /note="C3H1-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   ZN_FING         314..344
FT                   /note="C3H1-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          243..269
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          414..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..19
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        243..254
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        451..460
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         186
FT                   /note="Phosphothreonine; by mbk-2"
FT                   /evidence="ECO:0000269|PubMed:18199581"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18842813"
FT   MUTAGEN         186
FT                   /note="T->A: Abolishes phosphorylation. Reduced embryo
FT                   viability and, pie-1 and mex-5 degradation in embryonic
FT                   somatic cells. Severe reduction in binding to plk-1 and
FT                   plk-2. Prevent subsequent phosphorylation by plk-1."
FT                   /evidence="ECO:0000269|PubMed:18199581"
FT   MUTAGEN         186
FT                   /note="T->D,E: Phosphomimetic mutant which severely
FT                   abolishes interaction with plk-1 and plk-2."
FT                   /evidence="ECO:0000269|PubMed:18199581"
FT   MUTAGEN         458
FT                   /note="S->A: Loss of phosphorylation and zygotic
FT                   asymmetry."
FT                   /evidence="ECO:0000269|PubMed:18842813"
FT   STRAND          321..324
FT                   /evidence="ECO:0007829|PDB:6PMG"
FT   HELIX           334..336
FT                   /evidence="ECO:0007829|PDB:6PMG"
SQ   SEQUENCE   468 AA;  52820 MW;  6B0E6FC4971CF5CD CRC64;
     MKAASNSVSS AGGSVSPTTT QPPLPPGQSS HPQIYDQQMQ YYFAAAMPNQ PMATYAAQNG
     SSQQYAPAAP YYQDANGQYV QVPANGSMAP QQHMMVSGQP YLYMAQPQQG AQQVMQSGQP
     QLIYYQQSMA PQAAPMYFHP MQAAPMLPEQ MGVMPHTQPA IPPQQQPRQV GVEISSTRTA
     PLTSSTPLPT SLEYETVQRD NRNRNIQFRY HRVMEHDELP IDEISKITLD NHNDDTMSAE
     KENHFHEHRG EKFGRRGFPI PETDSQQPPN YKTRLCMMHA SGIKPCDMGA RCKFAHGLKE
     LRATDAPARY PNNKYKTKLC KNFARGGTGF CPYGLRCEFV HPTDKEFQNI PPYQRMSHDD
     QDYDQDVIPE DYVVARHQPR FMRTGGRATT PTKVMLKHRN VAGSMMCLSN AGRDLQAGGD
     YNQPESNEDD LPPHLRRNRR ENPPMNKRRT SLSTKWTSEE NLGLRGHY
//
